spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Vivo Ventures 

 HSMN NewsFeed - 22 Jun 2016
AirXpanders' AeroForm(R) Tissue Expander Technology Showcased at Three International Surgery Conferences
Devices Surgery Oncology
 HSMN NewsFeed - 15 Apr 2014
Interim Results of AirXpanders' Multi-Centered Randomized Controlled Trial Demonstrate Faster, Needle-Free Alternative to Saline Tissue Expanders
Devices
 HSMN NewsFeed - 30 Jan 2013
MEI Pharma Announces Retirement Of Chairman Bryan Williams From Board Of Directors And Appointment Of Christine White As Lead Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jun 2012
Ceptaris Secures $10 Million in Series D-1 Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jun 2012
SentreHEART Secures $26 Million in Series C Financing for Commercialization
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 21 Feb 2012
Ceptaris Secures $15M in Venture Debt Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 23 Jan 2012
AirXpanders Secures $10M in Series D Financing
Devices Oncology Venture Capital
 HSMN NewsFeed - 11 Aug 2011
Yaupon Therapeutics, Inc. Secures $14.4 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 10 Jun 2011
Revance Announces $45 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 May 2011
Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
Venture Capital Personnel
 HSMN NewsFeed - 9 May 2011
Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2011
NextWave Pharmaceuticals Secures $45 Million in Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Jan 2010
Neomend Completes $30M Funding with Clarus Ventures, Other Investors
Devices Surgery Venture Capital
 HSMN NewsFeed - 4 Jan 2010
Revance Announces Series D Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 26 Feb 2009
Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Sep 2008
APT Pharmaceuticals Secures $32 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Sep 2008
Sagent Completes $30 Million Series A Financing Extension
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 May 2008
Revance Announces Series C Expansion
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Dec 2007
APT Pharmaceuticals Adds Paul Sekhri to Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 26 Nov 2007
Yaupon Therapeutics Closes $14.5 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Nov 2007
Carbylan Announces $20 Million Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 19 Nov 2007
APT Pharmaceuticals Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2007
APT Pharmaceuticals Closes New $22 Million Funding Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Sep 2007
Sagent Pharmaceuticals Inc. Completes $53 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Jul 2007
Neuren to Obtain Late Stage Compound Through Hamilton Pharmaceuticals Acquisition
Biopharmaceuticals Acquisitions Neurology
 HSMN NewsFeed - 5 Jun 2007
APT Acquires Exclusive Worldwide Rights to Develop and Commercialize Inhalable Cyclosporine to Prevent Lung Transplant Rejection
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 6 Mar 2007
TransOral Pharmaceuticals Raises $40 Million in Series D Financing. Proceeds Will Be Used to Complete Intermezzo(TM) Phase 3 Clinical Trials and File NDA
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jan 2007
InteKrin Therapeutics Secures $23 M Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Jan 2007
Capnia Announces Appointment of Joseph J. Vallner as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Sep 2006
Former Chiron Exec Joins APT Pharmaceuticals as CEO
Biopharmaceuticals Personnel
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.